Trials / Sponsors / Craig Portell, MD
Craig Portell, MD
Academic / Other · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Optimal Dose Finding Study ABT-199 and Ibrutinib in MCL Lymphoma, Mantle-Cell, Recurrent Lymphoma, Mantle-Cell | Phase 1 | 2015-04-01 |